[
  {
    "ts": "2025-05-08T13:30:00+00:00",
    "headline": "Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing",
    "summary": "Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools today announced a partnership aimed at streamlining gene delivery solutions for the development and manufacture of advanced cell therapies. The collaboration will focus on the synergies developers can achieve by utilizing the TcBuster™ GMP non-viral genome engineering system and the Flowfect Tx™ GMP cellular",
    "url": "https://finance.yahoo.com/news/kytopen-bio-techne-collaborate-integrated-133000098.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "ece83f52-a1bc-38be-8996-c62e9dbca3da",
      "content": {
        "id": "ece83f52-a1bc-38be-8996-c62e9dbca3da",
        "contentType": "STORY",
        "title": "Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing",
        "description": "",
        "summary": "Kytopen Corp., a leader in providing continuous flow cellular engineering technologies and Bio-Techne Corporation (NASDAQ: TECH), a leading provider of innovative life science research tools today announced a partnership aimed at streamlining gene delivery solutions for the development and manufacture of advanced cell therapies. The collaboration will focus on the synergies developers can achieve by utilizing the TcBuster™ GMP non-viral genome engineering system and the Flowfect Tx™ GMP cellular",
        "pubDate": "2025-05-08T13:30:00Z",
        "displayTime": "2025-05-08T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/55b19cf3b0bd56c662199ac8f96086f0",
          "originalWidth": 400,
          "originalHeight": 65,
          "caption": "Kytopen Logo (PRNewsfoto/Kytopen)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Bwv.9hC4GRrRK.q2VBzPg--~B/aD02NTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/55b19cf3b0bd56c662199ac8f96086f0.cf.webp",
              "width": 400,
              "height": 65,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pGkYwrt_sRRVDn6.MYv5cQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/55b19cf3b0bd56c662199ac8f96086f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kytopen-bio-techne-collaborate-integrated-133000098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kytopen-bio-techne-collaborate-integrated-133000098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-05-08T11:00:00+00:00",
    "headline": "Bio-Techne to Present at the BofA Securities 2025 Health Care Conference",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
    "url": "https://finance.yahoo.com/news/bio-techne-present-bofa-securities-110000553.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "406ebd4d-fafb-3fd9-9032-5d9714108762",
      "content": {
        "id": "406ebd4d-fafb-3fd9-9032-5d9714108762",
        "contentType": "STORY",
        "title": "Bio-Techne to Present at the BofA Securities 2025 Health Care Conference",
        "description": "",
        "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. A live webcast of the presentation can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.",
        "pubDate": "2025-05-08T11:00:00Z",
        "displayTime": "2025-05-08T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c",
          "originalWidth": 400,
          "originalHeight": 146,
          "caption": "BT Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kJl8lfxgQq52fwY.Vvxfgw--~B/aD0xNDY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c.cf.webp",
              "width": 400,
              "height": 146,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tkFsOYbYoGS0nXbE3BaqwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f5bd457eba951c97e17e98b5c3c3878c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-bofa-securities-110000553.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-present-bofa-securities-110000553.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-05-08T07:16:09+00:00",
    "headline": "Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ...",
    "summary": "Bio-Techne Corp (TECH) reports a 6% organic revenue increase and robust performance in protein sciences, despite facing macroeconomic uncertainties and tariff impacts.",
    "url": "https://finance.yahoo.com/news/bio-techne-corp-tech-q3-071609385.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "7bdee96f-263f-3d0a-8770-003c48d761db",
      "content": {
        "id": "7bdee96f-263f-3d0a-8770-003c48d761db",
        "contentType": "STORY",
        "title": "Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ...",
        "description": "",
        "summary": "Bio-Techne Corp (TECH) reports a 6% organic revenue increase and robust performance in protein sciences, despite facing macroeconomic uncertainties and tariff impacts.",
        "pubDate": "2025-05-08T07:16:09Z",
        "displayTime": "2025-05-08T07:16:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/f1a50059a53ad2e2c582170065cb9272",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8wxeIsaN4UwwpSvTY1ohUg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f1a50059a53ad2e2c582170065cb9272.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wiazsuB2cW1fZ7mAwZ47XQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f1a50059a53ad2e2c582170065cb9272.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-corp-tech-q3-071609385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-corp-tech-q3-071609385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]